Select Medical (SEM) reported Q3 adjusted earnings late Thursday of $0.50 per share, up from $0.46 a year earlier.
Analysts polled by Capital IQ expected $0.43.
Revenue for the quarter ended Sept. 30 was $1.76 billion, up from $1.67 billion a year earlier.
Analysts surveyed by Capital IQ expected $1.74 billion.
The company said its 2024 adjusted earnings will likely be $2.09 to $2.20 per share compared with a previous guidance of $1.96 to $2.20 per share. Analysts surveyed by Capital IQ expect $2.09.
The company now expects full-year revenue of $6.95 billion to $7.15 billion from $6.9 billion to $7.1 billion, previously. Analysts polled by Capital IQ expect $7.03 billion.
Shares of Select Medical traded 5.1% higher in after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.